ISOPROTERENOL HYDROCHLORIDE

ISOPROTERENOL HYDROCHLORIDE was reported 436 times

ISOPROTERENOL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ELECTROCARDIOGRAM RR INTERVAL ABNORMAL 1 0.3333
1 REDUCED PARASYMPATHETIC ACTIVITY 1 0.1667
2 ELECTROCARDIOGRAM J WAVE INCREASED 1 0.1000
3 BILE CAST NEPHROPATHY 2 0.0645
4 DELAYED ISCHAEMIC NEUROLOGICAL DEFICIT 1 0.0476
5 ELECTROCARDIOGRAM RR INTERVAL PROLONGED 2 0.0444
6 ARRHYTHMIC STORM 11 0.0329
7 DEVICE PACING ISSUE 2 0.0235
8 MULTI-VITAMIN DEFICIENCY 1 0.0233
9 ACQUIRED LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 1 0.0204
10 CARBOXYHAEMOGLOBIN INCREASED 1 0.0167
11 CARDIAC INDEX DECREASED 1 0.0097
12 VENTRICULAR DYSSYNCHRONY 1 0.0090
13 BLOOD METHAEMOGLOBIN PRESENT 1 0.0090
14 GALLBLADDER RUPTURE 4 0.0086
15 ACHROMOBACTER INFECTION 1 0.0083
16 NODAL ARRHYTHMIA 7 0.0081
17 NECROTISING OESOPHAGITIS 4 0.0080
18 PNEUMONIA ACINETOBACTER 1 0.0073
19 HYPOTENSIVE CRISIS 1 0.0069
20 PERITONEAL HAEMATOMA 1 0.0067
21 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 7 0.0066
22 MITOCHONDRIAL TOXICITY 5 0.0061
23 ACUTE RIGHT VENTRICULAR FAILURE 1 0.0059
24 BASE EXCESS DECREASED 1 0.0056
25 FLOPPY INFANT 1 0.0054
26 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 2 0.0052
27 TORSADE DE POINTES 40 0.0051
28 NORMOCHROMIC ANAEMIA 1 0.0050
29 HAEMOPERITONEUM 4 0.0050
30 ACUTE CHOLECYSTITIS NECROTIC 1 0.0050
31 SKULL FRACTURED BASE 1 0.0040
32 APNOEA NEONATAL 1 0.0039
33 HYPOPERFUSION 4 0.0038
34 LONG QT SYNDROME 8 0.0033
35 FUNGAL ENDOCARDITIS 1 0.0033
36 HEPATIC ISCHAEMIA 1 0.0032
37 ANTICOAGULATION DRUG LEVEL INCREASED 1 0.0031
38 PNEUMONITIS ASPIRATION 1 0.0029
39 HEART TRANSPLANT REJECTION 3 0.0029
40 ATRIAL TACHYCARDIA 6 0.0029
41 PROPOFOL INFUSION SYNDROME 2 0.0028
42 CEREBRAL ARTERY OCCLUSION 3 0.0028
43 RESPIRATORY GAS EXCHANGE DISORDER 1 0.0027
44 ALKALOSIS 1 0.0026
45 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 5 0.0025
46 SPINAL CORD HAEMORRHAGE 1 0.0025
47 HAEMOBILIA 1 0.0024
48 PSEUDOMONAL BACTERAEMIA 2 0.0023
49 SPINAL CORD INFARCTION 1 0.0023
50 STRESS CARDIOMYOPATHY 13 0.0022
51 CLONUS 6 0.0022
52 BRASH SYNDROME 3 0.0021
53 WOLFF-PARKINSON-WHITE SYNDROME 1 0.0021
54 LABELLED DRUG-DRUG INTERACTION ISSUE 3 0.0021
55 HEMIANOPIA 2 0.0020
56 TACHYCARDIA FOETAL 1 0.0020
57 GINGIVAL HYPERTROPHY 3 0.0020
58 VENTRICULAR FIBRILLATION 21 0.0019
59 ATRIOVENTRICULAR BLOCK COMPLETE 12 0.0018
60 ARTERIOSPASM CORONARY 7 0.0017
61 PO2 DECREASED 2 0.0017
62 SICK SINUS SYNDROME 2 0.0017
63 CHEMICAL BURN 2 0.0017
64 NEPHROGENIC DIABETES INSIPIDUS 2 0.0017
65 ACUTE LUNG INJURY 2 0.0017
66 SINUS NODE DYSFUNCTION 3 0.0016
67 VENTRICULAR TACHYCARDIA 27 0.0016
68 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 1 0.0015
69 CARDIOGENIC SHOCK 21 0.0015
70 TOXIC EPIDERMAL NECROLYSIS 22 0.0014
71 PRODUCT EXPIRATION DATE ISSUE 2 0.0014
72 PCO2 INCREASED 1 0.0014
73 PRODUCT DESIGN ISSUE 1 0.0014
74 NODAL RHYTHM 2 0.0014
75 HAEMORRHAGIC TRANSFORMATION STROKE 2 0.0013
76 MULTIPLE DRUG THERAPY 1 0.0013
77 ATRIOVENTRICULAR BLOCK SECOND DEGREE 4 0.0013
78 ATRIOVENTRICULAR BLOCK 10 0.0013
79 SINUS ARREST 2 0.0013
80 BLOOD FIBRINOGEN INCREASED 1 0.0013
81 IMMUNE-MEDIATED MYOCARDITIS 2 0.0012
82 VASOPLEGIA SYNDROME 2 0.0012
83 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
84 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 6 0.0012
85 VASOCONSTRICTION 1 0.0011
86 CARDIAC OUTPUT DECREASED 1 0.0011
87 BRADYPNOEA 3 0.0011
88 CONDUCTION DISORDER 2 0.0011
89 DRUG LEVEL ABOVE THERAPEUTIC 5 0.0011
90 DISORGANISED SPEECH 2 0.0011
91 PRODUCT APPEARANCE CONFUSION 1 0.0011
92 NECK MASS 3 0.0011
93 SINUS BRADYCARDIA 10 0.0010
94 ULNA FRACTURE 1 0.0010
95 BLADDER CANCER RECURRENT 1 0.0010
96 VENTRICULAR EXTRASYSTOLES 10 0.0010
97 INSULIN RESISTANCE 2 0.0010
98 PULSELESS ELECTRICAL ACTIVITY 4 0.0010
99 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 3 0.0009
100 LIP DISCOLOURATION 1 0.0008
101 WEIGHT LOSS POOR 4 0.0008
102 TONIC CLONIC MOVEMENTS 1 0.0008
103 DRUG CLEARANCE DECREASED 1 0.0008
104 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
105 THROMBOCYTOPENIC PURPURA 1 0.0007
106 ISCHAEMIC HEPATITIS 1 0.0007
107 ECHOCARDIOGRAM ABNORMAL 1 0.0007
108 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
109 BUNDLE BRANCH BLOCK LEFT 3 0.0007
110 ELECTROCARDIOGRAM QT PROLONGED 25 0.0007
111 CARDIOTOXICITY 6 0.0007
112 HYPERTHERMIA MALIGNANT 1 0.0007
113 PNEUMONIA PSEUDOMONAL 1 0.0007
114 SUDDEN CARDIAC DEATH 2 0.0006
115 BLOOD PH DECREASED 1 0.0006
116 PUPIL FIXED 1 0.0006
117 VENTRICULAR ARRHYTHMIA 2 0.0005
118 TUNNEL VISION 1 0.0005
119 ACIDOSIS 4 0.0005
120 PNEUMONIA FUNGAL 2 0.0005
121 POLYDIPSIA 2 0.0005
122 RENAL HAEMORRHAGE 1 0.0005
123 OLIGURIA 3 0.0005
124 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
125 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
126 ISCHAEMIA 2 0.0004
127 SINUS TACHYCARDIA 6 0.0004
128 RADIUS FRACTURE 1 0.0004
129 PRODUCT PACKAGING CONFUSION 1 0.0004
130 BRONCHITIS CHRONIC 1 0.0004
131 TRANSPLANT FAILURE 1 0.0004
132 EXPIRED DRUG ADMINISTERED 2 0.0004
133 TACHYARRHYTHMIA 1 0.0004
134 CATHETER SITE HAEMORRHAGE 1 0.0004
135 VASODILATATION 1 0.0004
136 HAEMODYNAMIC INSTABILITY 3 0.0004
137 SEDATION COMPLICATION 1 0.0004
138 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
139 BRADYCARDIA 20 0.0004
140 PREMATURE DELIVERY 6 0.0004
141 AREFLEXIA 1 0.0004
142 MYASTHENIA GRAVIS 3 0.0004
143 MYOCARDITIS 4 0.0003
144 PARAPLEGIA 1 0.0003
145 HAEMOTHORAX 1 0.0003
146 PRODUCT LABEL CONFUSION 2 0.0003
147 COVID-19 PNEUMONIA 4 0.0003
148 HEPATITIS CHOLESTATIC 2 0.0003
149 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
150 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
151 VENTRICULAR HYPOKINESIA 1 0.0003
152 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
153 INCOHERENT 2 0.0003
154 FIBRIN D DIMER INCREASED 1 0.0003
155 HAEMORRHAGIC DIATHESIS 1 0.0003
156 VISUAL FIELD DEFECT 2 0.0003
157 REBOUND EFFECT 3 0.0003
158 CAESAREAN SECTION 3 0.0003
159 ORAL HERPES 5 0.0003
160 NEUROLEPTIC MALIGNANT SYNDROME 3 0.0003
161 ATRIAL FLUTTER 2 0.0003
162 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
163 PERIPHERAL ISCHAEMIA 1 0.0002
164 RESPIRATORY DEPRESSION 3 0.0002
165 POLYURIA 2 0.0002
166 ANAPHYLACTOID REACTION 1 0.0002
167 COAGULOPATHY 4 0.0002
168 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
169 ARRHYTHMIA 11 0.0002
170 CARDIAC ARREST 19 0.0002
171 RHINITIS ALLERGIC 1 0.0002
172 TACHYPNOEA 3 0.0002
173 PULSE ABSENT 1 0.0002
174 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
175 CEREBRAL ISCHAEMIA 1 0.0002
176 BLOOD LACTIC ACID INCREASED 1 0.0002
177 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
178 DRUG LEVEL INCREASED 3 0.0002
179 INTRACRANIAL PRESSURE INCREASED 1 0.0002
180 NEPHROPATHY TOXIC 2 0.0002
181 MYOCARDIAL ISCHAEMIA 2 0.0002
182 HYPERVENTILATION 1 0.0002
183 CARDIAC PACEMAKER INSERTION 1 0.0002
184 DIABETIC KETOACIDOSIS 4 0.0002
185 PREMATURE BABY 5 0.0002
186 EXPOSURE DURING PREGNANCY 10 0.0002
187 METABOLIC ACIDOSIS 5 0.0002
188 MYDRIASIS 2 0.0002
189 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
190 POST-TRAUMATIC STRESS DISORDER 1 0.0001
191 WRONG PRODUCT ADMINISTERED 1 0.0001
192 BONE MARROW FAILURE 3 0.0001
193 DRUG INTERACTION 23 0.0001
194 ENCEPHALITIS 1 0.0001
195 ATRIAL FIBRILLATION 14 0.0001
196 EXTRASYSTOLES 1 0.0001
197 DUODENAL ULCER 1 0.0001
198 DIALYSIS 2 0.0001
199 SUBDURAL HAEMATOMA 2 0.0001
200 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
201 SHOCK 3 0.0001
202 PROCEDURAL COMPLICATION 1 0.0001
203 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
204 EJECTION FRACTION DECREASED 2 0.0001
205 APNOEA 1 0.0001
206 CYANOSIS 2 0.0001
207 PNEUMOTHORAX 2 0.0001
208 COMA 6 0.0001
209 INTENTIONAL OVERDOSE 8 0.0001
210 TOXICITY TO VARIOUS AGENTS 21 0.0001
211 BLOOD POTASSIUM INCREASED 2 0.0001
212 CEREBRAL INFARCTION 3 0.0001
213 PNEUMONIA ASPIRATION 3 0.0001
214 DRUG USE DISORDER 1 0.0001
215 CIRCULATORY COLLAPSE 2 0.0001
216 MYOPATHY 1 0.0001
217 NEUROTOXICITY 2 0.0001
218 HEART RATE DECREASED 4 0.0001
219 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
220 WRONG DRUG ADMINISTERED 1 0.0001
221 ISCHAEMIC STROKE 2 0.0001
222 MYOSITIS 1 0.0001
223 BLOOD BILIRUBIN INCREASED 3 0.0001
224 PNEUMONIA BACTERIAL 1 0.0001
225 TREATMENT FAILURE 9 0.0001
226 POISONING DELIBERATE 1 0.0001
227 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
228 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
229 HAEMATOCRIT DECREASED 2 0.0001
230 HYPOTONIA 1 0.0001
231 BRAIN INJURY 1 0.0001
232 APHASIA 3 0.0001
233 DRUG LEVEL DECREASED 1 0.0001
234 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
235 TEMPERATURE INTOLERANCE 1 0.0001
236 PULMONARY HYPERTENSION 2 0.0001
237 RESPIRATORY FAILURE 7 0.0001
238 HYPOTENSION 19 0.0001
239 ACUTE KIDNEY INJURY 14 0.0001
240 DRUG INEFFECTIVE 120 0.0001
241 TOOTH FRACTURE 1 0.0001
242 THERAPY NON-RESPONDER 4 0.0001
243 MITRAL VALVE INCOMPETENCE 1 0.0001
244 HYPOXIA 3 0.0001
245 ATAXIA 1 0.0001
246 CHOLECYSTITIS 1 0.0001
247 OVERDOSE 18 0.0001
248 ILEUS 1 0.0001
249 BRAIN OEDEMA 1 0.0001
250 DRUG RESISTANCE 2 0.0001
251 HAEMATOMA 2 0.0001
252 PULMONARY CONGESTION 1 0.0001
253 SINUS CONGESTION 1 0.0001
254 DRUG TOXICITY 1 0.0001
255 PERIPHERAL COLDNESS 1 0.0001
256 HYPOMAGNESAEMIA 1 0.0001
257 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
258 RENAL FAILURE ACUTE 3 0.0001
259 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
260 PARALYSIS 1 0.0001
261 HYPOKINESIA 1 0.0001
262 CARDIOMYOPATHY 1 0.0001
263 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
264 THYROID DISORDER 1 0.0001
265 LUNG INFECTION 1 0.0001
266 THERAPY PARTIAL RESPONDER 1 0.0001
267 DRUG-INDUCED LIVER INJURY 2 0.0001
268 PRODUCT USE COMPLAINT 1 0.0001
269 HYPOTHYROIDISM 2 0.0001
270 LACTIC ACIDOSIS 2 0.0001
271 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
272 SEIZURE 7 0.0001
273 PRODUCT USE IN UNAPPROVED INDICATION 15 0.0001
274 SYNCOPE 6 0.0001
275 PERICARDITIS 1 0.0001
276 CONDITION AGGRAVATED 18 0.0001
277 MULTI-ORGAN FAILURE 1 0.0001
278 ORTHOSTATIC HYPOTENSION 1 0.0001
279 HYPERKALAEMIA 2 0.0001
280 PANCREATITIS 3 0.0001
281 CEREBRAL HAEMORRHAGE 2 0.0001
282 AGRANULOCYTOSIS 1 0.0001
283 BACTERIAL INFECTION 1 0.0001
284 HEPATIC FUNCTION ABNORMAL 2 0.0001
285 FRACTURE 1 0.0001
286 RENAL FAILURE 7 0.0001
287 ACUTE RESPIRATORY FAILURE 1 0.0001
288 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
289 DISORIENTATION 2 0.0001
290 PREGNANCY 1 0.0000
291 OEDEMA PERIPHERAL 6 0.0000
292 BODY TEMPERATURE INCREASED 1 0.0000
293 DRUG ABUSE 4 0.0000
294 RHABDOMYOLYSIS 2 0.0000
295 HALLUCINATION, VISUAL 1 0.0000
296 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
297 PRODUCT DISPENSING ERROR 1 0.0000
298 INTENTIONAL PRODUCT MISUSE 4 0.0000
299 OFF LABEL USE 40 0.0000
300 PANCREATITIS ACUTE 1 0.0000
301 HEART RATE IRREGULAR 1 0.0000
302 DEVICE MALFUNCTION 3 0.0000
303 DISEASE RECURRENCE 2 0.0000
304 PRODUCT PRESCRIBING ERROR 1 0.0000
305 BLOOD PRESSURE FLUCTUATION 1 0.0000
306 JOINT SWELLING 5 0.0000
307 INTERSTITIAL LUNG DISEASE 2 0.0000
308 MENTAL IMPAIRMENT 1 0.0000
309 HYPOGLYCAEMIA 2 0.0000
310 PRESYNCOPE 1 0.0000
311 NEURALGIA 1 0.0000
312 AGITATION 3 0.0000
313 LIVER INJURY 1 0.0000
314 ENCEPHALOPATHY 1 0.0000
315 CHRONIC KIDNEY DISEASE 3 0.0000
316 HEPATITIS 1 0.0000
317 EXPOSURE VIA SKIN CONTACT 1 0.0000
318 PLATELET COUNT DECREASED 4 0.0000
319 RESPIRATORY ARREST 1 0.0000
320 RESPIRATORY DISTRESS 1 0.0000
321 MENTAL STATUS CHANGES 1 0.0000
322 OXYGEN SATURATION DECREASED 2 0.0000
323 HERPES ZOSTER 2 0.0000
324 DRUG WITHDRAWAL SYNDROME 3 0.0000
325 ACUTE MYOCARDIAL INFARCTION 1 0.0000
326 BLOOD POTASSIUM DECREASED 1 0.0000
327 HEPATIC FAILURE 1 0.0000
328 MOVEMENT DISORDER 1 0.0000
329 HEART RATE INCREASED 3 0.0000
330 EXPIRED PRODUCT ADMINISTERED 1 0.0000
331 ABDOMINAL DISCOMFORT 5 0.0000
332 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
333 ACCIDENTAL OVERDOSE 1 0.0000
334 THROMBOCYTOPENIA 3 0.0000
335 BLOOD PRESSURE INCREASED 4 0.0000
336 ABORTION SPONTANEOUS 1 0.0000
337 CARDIAC FAILURE 2 0.0000
338 CARDIAC FAILURE CONGESTIVE 2 0.0000
339 THROMBOSIS 2 0.0000
340 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
341 CARDIO-RESPIRATORY ARREST 1 0.0000
342 ROAD TRAFFIC ACCIDENT 1 0.0000
343 WITHDRAWAL SYNDROME 1 0.0000
344 LOSS OF CONSCIOUSNESS 3 0.0000
345 SEPTIC SHOCK 1 0.0000
346 MENTAL DISORDER 1 0.0000
347 MYOCARDIAL INFARCTION 4 0.0000
348 LIVER DISORDER 1 0.0000
349 TINNITUS 1 0.0000
350 HYPOKALAEMIA 1 0.0000
351 WEIGHT DECREASED 6 0.0000
352 CARDIAC DISORDER 2 0.0000
353 RASH ERYTHEMATOUS 1 0.0000
354 CONTUSION 2 0.0000
355 CHEST DISCOMFORT 2 0.0000
356 DYSPNOEA 11 0.0000
357 NERVOUSNESS 1 0.0000
358 CONFUSIONAL STATE 3 0.0000
359 OEDEMA 1 0.0000
360 ANAPHYLACTIC REACTION 1 0.0000
361 TREMOR 3 0.0000
362 WEIGHT INCREASED 4 0.0000
363 HYPONATRAEMIA 1 0.0000
364 MUSCULAR WEAKNESS 2 0.0000
365 CONVULSION 1 0.0000
366 PALPITATIONS 2 0.0000
367 CHILLS 2 0.0000
368 DISEASE PROGRESSION 2 0.0000
369 WHEEZING 1 0.0000
370 SUICIDE ATTEMPT 1 0.0000
371 PLEURAL EFFUSION 1 0.0000
372 PRODUCT USE ISSUE 3 0.0000
373 BLOOD CREATININE INCREASED 1 0.0000
374 INFUSION RELATED REACTION 1 0.0000
375 FEBRILE NEUTROPENIA 1 0.0000
376 BLOOD PRESSURE DECREASED 1 0.0000
377 DEHYDRATION 2 0.0000
378 PYREXIA 5 0.0000
379 INJURY 1 0.0000
380 HYPERTENSION 3 0.0000
381 EPISTAXIS 1 0.0000
382 RENAL IMPAIRMENT 1 0.0000
383 TACHYCARDIA 1 0.0000
384 CHEST PAIN 2 0.0000
385 HYPERSENSITIVITY 2 0.0000
386 DRUG INTOLERANCE 1 0.0000
387 FLUSHING 1 0.0000
388 SINUSITIS 1 0.0000
389 HAEMOGLOBIN DECREASED 1 0.0000
390 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
391 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
392 SEPSIS 1 0.0000
393 DIZZINESS 4 0.0000
394 HYPERHIDROSIS 1 0.0000
395 NAUSEA 6 0.0000
396 VISION BLURRED 1 0.0000
397 PERIPHERAL SWELLING 1 0.0000
398 VOMITING 3 0.0000
399 HEADACHE 4 0.0000
400 DRUG DEPENDENCE 1 0.0000
401 PNEUMONIA 2 0.0000
402 FALL 2 0.0000
403 NO ADVERSE EVENT 1 0.0000
404 MUSCLE SPASMS 1 0.0000
405 NASOPHARYNGITIS 1 0.0000
406 BLOOD GLUCOSE INCREASED 1 0.0000
407 ANAEMIA 1 0.0000
408 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
409 MALAISE 2 0.0000
410 INCORRECT DOSE ADMINISTERED 1 0.0000
411 BACK PAIN 1 0.0000
412 FEELING ABNORMAL 1 0.0000
413 PRURITUS 1 0.0000
414 FATIGUE 2 0.0000
415 ARTHRALGIA 1 0.0000
416 DEATH 2 0.0000
417 RASH 1 0.0000
418 DIARRHOEA 1 0.0000